NasdaqGM - Nasdaq Real Time Price USD

Gain Therapeutics, Inc. (GANX)

Compare
1.5600 -0.0100 (-0.64%)
At close: December 20 at 4:00:02 PM EST
1.5501 -0.01 (-0.63%)
After hours: December 20 at 5:14:58 PM EST

Insider Roster

Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.

Individual or EntityMost Recent TransactionDateShares Owned as of Transaction Date
ALDER MATTHIAS Chief Executive Officer Conversion of Exercise of derivative security Mar 26, 2024 21,140
ISLAM KHALID Officer and Director Purchase Aug 9, 2024 930,784
MACK GENE C Chief Executive Officer Purchase Aug 9, 2024 14,400
RICHMAN ERIC I. Director Purchase Jul 1, 2024 304,458
RILEY JEFFREY SCOTT Director Purchase Mar 28, 2024 30,000

Related Tickers